BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25984930)

  • 21. The Modified Glasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the Literature.
    Petrelli F; Barni S; Coinu A; Bertocchi P; Borgonovo K; Cabiddu M; Ghilardi M; Zaniboni A
    Rev Recent Clin Trials; 2015; 10(2):135-41. PubMed ID: 25778832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
    Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis.
    Zhuo Y; Lin L; Wei S; Zhang M
    Medicine (Baltimore); 2016 Dec; 95(52):e5706. PubMed ID: 28033270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
    Faloppi L; Bianconi M; Giampieri R; Sobrero A; Labianca R; Ferrari D; Barni S; Aitini E; Zaniboni A; Boni C; Caprioni F; Mosconi S; Fanello S; Berardi R; Bittoni A; Andrikou K; Cinquini M; Torri V; Scartozzi M; Cascinu S;
    Oncotarget; 2015 Oct; 6(33):35087-94. PubMed ID: 26397228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Wu M; Lin P; Xu L; Yu Z; Chen Q; Gu H; Liu C
    Front Oncol; 2020; 10():677. PubMed ID: 32509573
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.
    Zhang X; Guo M; Fan J; Lv Z; Huang Q; Han J; Wu F; Hu G; Xu J; Jin Y
    Cancer Biomark; 2016; 16(3):415-23. PubMed ID: 27062698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
    Perisanidis C; Psyrri A; Cohen EE; Engelmann J; Heinze G; Perisanidis B; Stift A; Filipits M; Kornek G; Nkenke E
    Cancer Treat Rev; 2015 Dec; 41(10):960-70. PubMed ID: 26604093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
    Fu Y; Lan T; Cai H; Lu A; Yu W
    Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: A meta-analysis of 18 observational studies.
    Gan J; Wang W; Yang Z; Pan J; Zheng L; Yin L
    Medicine (Baltimore); 2018 Nov; 97(46):e13151. PubMed ID: 30431587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis.
    Zhang Z; Li C; Fan H; Xiang Q; Xu L; Liu Q; Zhou S; Xie Q; Chen S; Mu G; Cui Y
    Breast Cancer Res Treat; 2018 Dec; 172(3):513-521. PubMed ID: 30159787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lactate dehydrogenase and survival following cancer diagnosis.
    Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Ng T; Van Hemelrijck M
    Br J Cancer; 2015 Nov; 113(9):1389-96. PubMed ID: 26469834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer: a systematic review and meta-analysis.
    Chen J; Zou X
    Front Oncol; 2023; 13():1247444. PubMed ID: 37727205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.
    Armstrong AJ; George DJ; Halabi S
    J Clin Oncol; 2012 Sep; 30(27):3402-7. PubMed ID: 22891270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis.
    Barua R; Templeton AJ; Seruga B; Ocana A; Amir E; Ethier JL
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):215-224. PubMed ID: 29395413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of preoperative serum lactate dehydrogenase in thymic carcinoma.
    Yuan ZY; Gao SG; Mu JW; Xue Q; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; He J
    J Thorac Dis; 2016 Sep; 8(9):2464-2472. PubMed ID: 27746998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.
    Wen S; Chen N; Hu Y; Huang L; Peng J; Yang M; Shen X; Song Y; Xu L
    Cancer Med; 2021 Mar; 10(5):1690-1714. PubMed ID: 33591628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
    Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
    Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
    Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.